InvestorsObserver is giving Dice Therapeutics Inc (DICE) an Analyst Rating Rank of 15, meaning DICE is ranked higher by analysts than 15% of stocks. The average price target for DICE is $53.727 and analyst’s rate the stock as a Buy.
Wall Street analysts are rating DICE a Buy today. Find out what this means to you and get the rest of the rankings on DICE!